Michael D. Clayman
2015
In 2015, Michael D. Clayman earned a total compensation of $3.2M as President, Chief Executive Officer and Co-Founder at Flexion Therapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $216,000 |
|---|---|
| Option Awards | $2,520,100 |
| Salary | $480,000 |
| Other | $24,239 |
| Total | $3,240,339 |
Clayman received $2.5M in option awards, accounting for 78% of the total pay in 2015.
Clayman also received $216K in bonus, $480K in salary and $24.2K in other compensation.
Rankings
In 2015, Michael D. Clayman's compensation ranked 2,878th out of 13,638 executives tracked by ExecPay. In other words, Clayman earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,878 out of 13,638 | 79th |
Division Manufacturing | 1,019 out of 5,190 | 80th |
Major group Chemicals And Allied Products | 377 out of 1,854 | 80th |
Industry group Drugs | 294 out of 1,528 | 81st |
Industry Pharmaceutical Preparations | 233 out of 1,182 | 80th |
Source: SEC filing on April 28, 2017.
Clayman's colleagues
We found two more compensation records of executives who worked with Michael D. Clayman at Flexion Therapeutics in 2015.